Suraksha Diagnostic Limited (NSE:SURAKSHA)

Market Cap	17.33B
Revenue (ttm)	2.56B
Net Income (ttm)	318.24M
Shares Out	52.08M
EPS (ttm)	5.97
PE Ratio	55.74
Forward PE	43.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,362
Average Volume	81,516
Open	330.35
Previous Close	332.75
Day's Range	324.95 - 336.00
52-Week Range	233.15 - 449.00
Beta	n/a
RSI	60.08
Earnings Date	May 28, 2025

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing; radiology testing, such as magnetic resonance imaging (MRI), computed tomography (CT) scan, dual-energy X-ray absorptiometry (DEXA) scan, interventional ultrasonography, CT guided biopsy, and X-Ray imaging services; and medical consultation services. The company was founded in 1992 and is based in based in Kolkata, India.

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 1,175
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SURAKSHA

Financial Performance

In 2024, Suraksha Diagnostic's revenue was 2.56 billion, an increase of 17.02% compared to the previous year's 2.19 billion. Earnings were 318.24 million, an increase of 34.70%.